关键词：甲型H1N1流感疫苗；增长；营收贡献；重大机遇
摘 要：The global H1N1 vaccines market is growing at a moderate rate and is expected to post a CAGR of 4.17% during the forecast period. In 2015, the major revenue contributor to this market was the Americas, followed by EMEA. However, there are major opportunities for the market in APAC to grow at a rapid rate, and increase its revenue contribution to the global market.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Disease overview

Understanding the disease

Causes of H1N1 diseases

Signs and symptoms

PART 06: Regulatory scenario of vaccines

PART 07: WHO recommendations for H1N1 vaccines

Key H1N1 virus vaccines for 2014-2015 season in US

H1N1 virus vaccines approved in EU

PART 08: Reimbursement for influenza vaccines in US

The US healthcare reform

Reimbursement for influenza vaccines

PART 09: Reimbursement for influenza vaccines in other

major countries

UK

Germany

Spain

Italy

France

Japan

PART 10: Market landscape

Global human vaccines market

Global H1N1 vaccines market

Five forces analysis

PART 11: Market segmentation by ROA

Intramuscular vaccines

Intranasal vaccines

Intradermal vaccines

PART 12: Geographical segmentation

Global H1N1 vaccines market by geographical

segmentation 2015-2020

H1N1 vaccines market in Americas

H1N1 vaccines market in EMEA

H1N1 vaccines market in APAC

PART 13: Market drivers

Global action plan for influenza vaccines

Increase in R&D

Inclusion in NIP

Rise in awareness

PART 14: Impact of drivers

PART 15: Market challenges

Antigenic drift and shift of H1N1v virus

Vaccine storage and handling issues

Stringent regulatory guidelines

Emergence of local players

PART 16: Impact of drivers and challenges

PART 17: Market trends

Universal influenza vaccine

Emergence of quadrivalent vaccines

Increase in strategic alliances and M&A

Improved understanding of immunology

PART 18: Vendor landscape

Competitive scenario

Market share analysis 2015

Sanofi

GSK

AstraZeneca

CSL

Other prominent vendors

PART 19: Appendix

List of abbreviations

PART 20: Explore Technavio